Samsara BioCapital, LLC Diversified Active

CIK: 0001744967 · Show all filings

Period: Q2 2020 (← Previous) (Next →)

Filing Date: Aug 14, 2020

Total Value ($000): $310,856 (100.0% shares, 0.0% debt)

Holdings (32)

Forma Therapeutics Holdings, Inc. 23.6%
Value ($000) $73,379 Shares 1,578,388 Est. Cost $46.49 Unrealized
Springworks Therapeutics Inc 7.5%
Value ($000) $23,409 Shares 557,356 Est. Cost $21.68 Unrealized
Odonate Therapeutics Inc 6.8%
Value ($000) $21,022 Shares 496,505 Est. Cost $14.81 Unrealized
Principia Biopharma Inc 6.6%
Value ($000) $20,505 Shares 342,946 Est. Cost $34.91 Unrealized
Intercept Pharmaceuticals Inc 6.2%
Value ($000) $19,341 Shares 403,688 Est. Cost $88.27 Unrealized
Allakos Inc 5.6%
Value ($000) $17,524 Shares 243,868 Est. Cost $51.45 Unrealized
Iveric Bio, Inc. 5.5%
Value ($000) $17,189 Shares 3,370,478 Est. Cost $5.74 Unrealized
Syros Pharmaceuticals Inc 5.1%
Value ($000) $15,866 Shares 1,571,903 Est. Cost $6.82 Unrealized
Sutro BioPharma Inc 4.2%
Value ($000) $13,002 Shares 1,675,579 Est. Cost $8.61 Unrealized
Atreca Inc 3.5%
Value ($000) $10,859 Shares 510,296 Est. Cost $18.84 Unrealized
Aeglea BioTherapeutics, Inc. 2.9%
Value ($000) $8,949 Shares 967,500 Est. Cost $9.25 Unrealized
GERN Genron Corporation 2.7%
Value ($000) $8,481 Shares 3,890,220 Est. Cost $1.49 Unrealized 0.0%
Aravive Inc 2.2%
Value ($000) $6,705 Shares 576,066 Est. Cost $5.87 Unrealized
RYTM Rhythm Pharmaceuticals Inc 2.0%
Value ($000) $6,161 Shares 276,289 Est. Cost $17.90 Unrealized +8.9%
FULC Fulcrum Therapeutics, Inc. 1.7%
Value ($000) $5,379 Shares 294,118 Est. Cost $15.75 Unrealized 0.0%
Portola Pharmaceuticals Inc 1.7%
Value ($000) $5,279 Shares 318,429 Est. Cost $11.84 Unrealized
Pieris Pharmaceuticals Inc 1.7%
Value ($000) $5,203 Shares 1,620,249 Est. Cost $2.86 Unrealized
Hookipa Pharma Inc 1.5%
Value ($000) $4,651 Shares 400,245 Est. Cost $6.73 Unrealized
ACRS Aclaris Therapeutics, Inc. 1.4%
Value ($000) $4,225 Shares 2,608,117 Est. Cost $1.36 Unrealized -1.6%
Aimmune Therapeutics, Inc. 1.3%
Value ($000) $3,886 Shares 232,571 Est. Cost $14.42 Unrealized
Kala Pharmaceuticals Inc 1.1%
Value ($000) $3,564 Shares 339,102 Est. Cost $10.18 Unrealized
Bellus Health Inc 1.1%
Value ($000) $3,450 Shares 333,631 Est. Cost $7.55 Unrealized
RCKT Rocket Pharmaceuticals Inc 0.9%
Value ($000) $2,892 Shares 138,197 Est. Cost $19.67 Unrealized -8.4%
KALV KalVista Pharmaceuticals Inc 0.7%
Value ($000) $2,035 Shares 168,174 Est. Cost $18.15 Unrealized -41.4%
Catabasis Pharmaceuticals Inc 0.6%
Value ($000) $1,929 Shares 300,000 Est. Cost $4.37 Unrealized
Soleno Therapeutics, Inc. 0.5%
Value ($000) $1,665 Shares 750,000 Est. Cost $2.22 Unrealized
UROV Urovant Sciences Ltd 0.5%
Value ($000) $1,550 Shares 157,480 Est. Cost $6.59 Unrealized
NGM Biopharmaceuticals, Inc. 0.3%
Value ($000) $959 Shares 48,602 Est. Cost $19.73 Unrealized
Assembly Biosciences Inc. 0.2%
Value ($000) $694 Shares 29,740 Est. Cost $23.34 Unrealized
Akero Therapeutics, Inc. 0.2%
Value ($000) $554 Shares 22,234 Est. Cost $21.20 Unrealized
Amarin Corp PLC 0.1%
Value ($000) $346 Shares 50,000 Est. Cost $4.00 Unrealized
Verona Pharma PLC. 0.1%
Value ($000) $203 Shares 43,456 Est. Cost $4.67 Unrealized